Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
BackgroundObsessive-compulsive disorder (OCD) is a psychiatric syndrome characterized by unwanted and repetitive thoughts and repeated ritualistic compulsions for decreasing distress. Symptoms can cause severe distress and functional impairment. OCD affects 2% to 3% of the po...
Main Authors: | Annalisa Maraone, Alessandro Trebbastoni, Antonella Di Vita, Fabrizia D'Antonio, Carlo De Lena, Massimo Pasquini |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2023-05-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2023/1/e39223 |
Similar Items
-
Memantine as an augmentation therapy in obsessive–Compulsive disorder
by: Parul Gupta, et al.
Published: (2019-01-01) -
The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)
by: Shahla Akouchekian, et al.
Published: (2018-01-01) -
Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
by: Hamid Afshar, et al.
Published: (2014-01-01) -
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
by: S. Askari
Published: (2023-03-01) -
Refractory obsessive-compulsive disorder: a challenging treatment
by: A.L. Ramos, et al.
Published: (2022-06-01)